Hugh Berry, MD
Pain Medicine · Saint Louis, MONPI 1831194935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Medtronic at 41.3% of the total.
Across 100 payments — averaging $41.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Nevro Corp.$825
- Abbott$645
- AbbVie$326
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$183
- Globus Medical$118
- plus $317 from 5 others
What the payments were for
- Food & beverage$4,116100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 57 | $1,701 |
| Nevro Corp. | 9 | $825 |
| Abbott | 13 | $645 |
| AbbVie(2 entities) | 13 | $326 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $183 |
| Globus Medical | 1 | $118 |
| Relievant Medsystems, Inc. | 1 | $104 |
| SPR Therapeutics, Inc | 1 | $92 |
| Protega Pharmaceutials Inc | 1 | $90 |
| Si-bone, Inc. | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$671
- Intracept$416
- INTELLIS ADAPTIVESTIM$349
- Proclaim Family of SCS IPGs$301
- Senza$254
- INTELLIS$153
- PROCLAIM$137
- INCEPTIV$131
- RELISTOR$128
- UBRELVY$123
- Proclaim IPG$113
How this compares
$4,116 in reported general payments places this provider in the 55th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 12 | $4,567 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 138 | $3,759 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 145 | $3,628 |
| Lidocaine | 15 | $1,325 |
| Morphine Sulfate | 33 | $1,237 |
| Gabapentin | 78 | $812 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $779 |
| Oxycodone Hcl | 43 | $772 |
| Pregabalin | 23 | $425 |
| Tizanidine Hcl | 74 | $424 |
| Tramadol Hcl | 36 | $188 |
| Baclofen | 15 | $186 |
| Methylprednisolone | 26 | $164 |
| Hydromorphone Hcl | 13 | $113 |
| Methocarbamol | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Saint Louis
- Vinicius Tieppo FrancioSaint Louis$35K
- Jooyoung MaengSaint Louis$25K
- Nabil AhmadSaint Louis$21K
- Katharine GurbaSaint Louis$18K
- Jeremy ThompsonSaint Louis$11K
- Alexander BeyzerSaint Louis$11K
- Hamed SadeghipourSaint Louis$10K
- Hess PanjetonSaint Louis$6K
- Xiaobin YiSaint Louis$6K
- Nicole ShinSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.